Every analytical method used in laboratory medicine can be fully described
in terms of its performance characteristics. Ideally, quality specification
s should be available for all of these, particularly precision and bias. Sp
ecifications for these can be set using a variety of strategies. Considerat
ion of the clinical settings of monitoring individual patients and diagnosi
s using reference intervals shows that generally applicable quality specifi
cations can be based on the components of biological variation, namely, wit
hin-subject [CVI] and between-subject [CVG] variation. Current consensus is
that precision should be < 1/2CV(I) and bias should be <1/4 [CVI2 + CVG2](
1/2). This strategy has advantages in that data on components of biological
variation are easily available on more than 180 quantities. Dissemination
of information on application of objective quality specifications needs att
ention from those involved in publication, manufacturers and organisers of
external quality assessment schemes.